VITA — Vitaminka AD Prilep Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedMicro CapContrarian

Annual balance sheet for Vitaminka AD Prilep, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	—	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	21.4	38.1	20.8	15.3	24.7
Net Total Accounts Receivable
Net Total Receivables	432	497	641	725	668
Total Inventory
Prepaid Expenses
Total Current Assets	864	1,035	1,321	1,486	1,507
Net Property, Plant And Equipment	1,380	1,366	1,429	1,545	1,507
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	2,314	2,523	2,915	3,121	3,194
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	663	589	903	1,045	1,063
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1,470	1,655	1,923	2,146	2,101
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	843	868	991	976	1,093
Total Liabilities & Shareholders' Equity	2,314	2,523	2,915	3,121	3,194
Total Common Shares Outstanding